Expert in Synthetic Organic Chemistry for Diagnostics, Pharma, and Biotechnology
Expert has developed 4 synthetic methods for small molecule linker conjugates (with a total of 15 steps) for antibody production and synthesis that are currently being used in late stage development and manufacturing of an in vitro diagnostic. Product launch is expected by 2018.
Expert has perfected a synthesis of an antigen-linker conjugate that overcame severe solubility and purification issues. He synthesized material for research, development and manufacturing. Product launch is expected in late 2017.
Expert has 20 publications and 13 patents or patent applications related to drug discovery and development in the following areas: antineoplastic agents, antiviral agents, CNS drugs, nonaddictive pain treatment, and antimicrobial agents.
Expert has developed self-assembling cytotoxins, a combintarial approach to target selective drug synergism.
Expert has optimized the purity in scaleup synthesis of a small molecule for pain treatment candidate, which has shown highly significant activity in clinical trials and has been awarded fast-track designation in a second trial in late 2016. He has also developed and completed synthetic methods for drug impurities to support stability studies.
The structure determination and synthetic procedure of a chiral drug candidate developed by Focus Synthesis was used in the client A’s pre-IND documentation to support a successful pre-IND meeting with the FDA that allowed clinical trials to begin in Q4 2014.
Expert has determined the structure of a highly unusual drug metabolite through synthesis of deuterated drug analogs, interpretation of the MS, and chemical synthesis.
As a consultant, Expert conducts the following:
Developing workarounds for synthetic chemistry and purification challenges, including redesign of molecules where needed.
Development of scalable synthetic strategies for diagnostic tool molecules and drug candidates.
Development of successful synthetic strategies for diagnostics, including a macrocycle requiring 14 steps.
Writing patent applications (with attorney).
Preparation of grant applications.
Design of patentable, synthetically accessible alternatives to existing bioactive molecules and fluorescent probes.
Determination of drug candidate metabolite structures.
Determination of structure of chiral molecules.
Development of novel, patentable ideas for molecular scale electronics.
Expert may consult nationally and internationally, and is also local to the following cities: New York, New York - Yonkers, New York - Newark, New Jersey - Jersey City, New Jersey - Paterson, New Jersey - Elizabeth, New Jersey - Bridgeport, Connecticut - New Haven, Connecticut - Stamford, Connecticut - Philadelphia, Pennsylvania
|Year: 1982||Degree: Ph.D.||Subject: Bioorganic Chemistry||Institution: Columbia University|
|Year: 1980||Degree: MS||Subject: Bioorganic Chemistry||Institution: Columbia University|
|Year: 1978||Degree: BA||Subject: Chemistry||Institution: Princeton University|
|Years: 2017 to Present||Employer: Undisclosed||Title: Independent Chemistry Consultant||Department:||Responsibilities: Expert undertakes synthetic organic chemistry consultation for diagnostic, pharma, and biotech companies.|
|Years: 2004 to 2016||Employer: Focus Synthesis LLC||Title: President, CEO, and founder||Department: Chemistry||Responsibilities: Expert was responsible for developing synthetic methods and designing patentable molecules and methods for diagonistics, pharma, biotech, and nutraceutical companies.|
|Associations / Societies|
|American Chemical Society|
|Awards / Recognition|
|Expert has been awarded several significant grants.|
|Publications and Patents Summary|
| Expert has had 20 articles published in Science, Nature, PNAS, JACS, and other journals related to drug discovery.
Expert has 13 patents and patent applications related to drug discovery and development in diabetes, cancer, viral infections, microbial infections, and hyperbilirubinemia. He has 4 additional patent applications submitted or in preparation for diagnostics, drug discovery, and nutraceuticals.
|Expert has vetted specialty and research chemical vendors in the U.S., India, China, the UK, and Canada.|
| Expert has been responsible for the marketing of catalog chemicals.
Expert has designed websites with over 2,000 research chemicals, searchable by chemical structure, CASRN, and chemical name. He has undertaken listing in multivendor catalogs (CHEMCATS, ACD, emolecules, chemexper, ChemAXS and others), which was found to be the most effective means of marketing chemical building blocks.
Expert is skilled and experienced in Google adwords and vendor booths at meetings. He has established successful vendor agreements with emolecules, Activate Scientific, Sigma Aldrich, and Chemnavigator.
|Other Relevant Experience|
|Expert's areas of consulting expertise include:
Synthetic organic chemistry for in-vitro and POC diagnostics
Applications: GI, nutritional deficienty, DNA sequencing
Molecules: Conjugates for antibody production, steroids, fluorescent probes, PCR tools, nucleotides, cryptates, nanotechnology.
Synthetic organic, medicinal, discovery, and development chemistry for Pharma
Applications: CNS, cancer, and pain.
Synthetic chemistry for nutraceuticals
|German||Can translate chemical journal articles to English.|